Maxwell John T. 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 18, 2020
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-03-16+60,000→ 60,000 totalExercise: $1.54Exp: 2030-03-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.